Riskpilot← Back to searchSign inGet full accessNORGESPLASTER AS
ASActiveOrg 995011727Granlivegen 21, 4707 VenneslaManufacture of pharmaceutical preparations · NACE 2120Est. 201054 employeeswww.norgesplaster.no
Revenue 2024
NOK 207,2M
+16% vs 2023
EBITDA margin
10.5%
+100% vs 2023
Equity ratio
16.3%
Financial strength
Net profit 2024
NOK 12,9M
+161% vs 2023
| Revenue | NOK 207,2M | +16% |
| EBITDA | NOK 21,7M | +100% |
| Net profit | NOK 12,9M | +161% |
| Total assets | NOK 110M | +31% |
| Equity | NOK 17,9M | -3% |
| Employees | 54 | — |
Legal name
NORGESPLASTER AS
Org number
995011727
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
16. januar 2010
Share capital
NOK 8 000 000
Employees
54 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Fremstilling, forskning og utvikling av, samt handel, herunder import og eksport, av farmasøytiske, medisinske og andre kjemiske produkter, samt andre produkter for behandling og forebygging av sykdommer, samt alt hva hermed står i forbindelse, herunder deltagelse i andre virksomheter.
Address
Granlivegen 21, 4707 Vennesla
Website
www.norgesplaster.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 88 885 | 99 124 | 100 268 | 162 780 | 169 398 | 169 950 | 169 446 | 190 450 | 192 807 | 178 969 | 207 204 |
| Staff expenses | −0 | −0 | −0 | −0 | −23 273 | −23 820 | −24 527 | −40 318 | −43 982 | −44 537 | −46 119 | −45 201 | −46 507 | −41 588 | −42 259 |
| EBITDA | 0 | 0 | 0 | 0 | 5 250 | 8 911 | 9 693 | 17 440 | 18 572 | 16 661 | 11 366 | 22 847 | 14 820 | 10 855 | 21 666 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −2 616 | −2 747 | −2 803 | −5 223 | −5 448 | −6 057 | −4 683 | −4 689 | −2 636 | −2 915 | −3 160 |
| EBIT | 0 | 0 | 0 | 0 | 2 634 | 6 164 | 6 889 | 12 218 | 13 124 | 10 604 | 6 683 | 18 158 | 12 184 | 7 940 | 18 506 |
| Net financials | 0 | 0 | 0 | 0 | −1 210 | −1 160 | −2 225 | −305 | −1 976 | −3 557 | −4 628 | −530 | 182 | −1 617 | −2 006 |
| Profit before tax | 0 | 0 | 0 | 0 | 1 423 | 5 004 | 4 664 | 11 913 | 11 148 | 7 047 | 2 055 | 17 628 | 12 365 | 6 323 | 16 500 |
| Tax | −0 | −0 | −0 | −0 | 390 | 1 548 | 1 210 | 3 263 | 2 963 | 1 946 | 838 | 4 273 | 2 723 | 1 402 | 3 643 |
| Net profit | 0 | 0 | 0 | 0 | 1 033 | 3 456 | 3 454 | 8 650 | 8 185 | 5 101 | 1 216 | 13 355 | 9 642 | 4 921 | 12 857 |
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | — | — | 55 612 | 55 487 | 53 732 | 84 558 | 83 762 | 91 323 | 92 969 | 89 265 | 93 155 | 83 801 | 109 992 |
| Equity | — | — | — | — | 11 139 | 10 941 | 10 116 | 23 817 | 20 445 | 26 283 | 36 229 | 18 084 | 18 429 | 18 499 | 17 933 |
| Long-term debt | 0 | 0 | 0 | 0 | 27 193 | 32 589 | 31 271 | 43 565 | 46 227 | 12 891 | 26 092 | 5 432 | 28 206 | 35 718 | 41 543 |
| Short-term debt | 0 | 0 | 0 | 0 | 17 280 | 11 957 | 12 344 | 17 177 | 17 090 | 52 149 | 30 648 | 65 749 | 46 520 | 29 584 | 50 516 |
| Total debt | 0 | 0 | 0 | 0 | 44 472 | 44 546 | 43 615 | 60 741 | 63 317 | 65 040 | 56 740 | 71 181 | 74 726 | 65 302 | 92 059 |
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
20102024
Equity ratio
16.3%
This company
38.2%
Market median
-57% vs market
20102024
Return on equity
71.7%
This company
18.4%
Market median
+290% vs market
20102024
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20102024
Asset turnover
1.88×
This company
1.12×
Market median
+68% vs market
20102024
Debt / equity
5.13×
This company
0.62×
Market median
-727% vs market
20102024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CT Deputy Member | Deputy Member | 2022 | — | — |
LA Deputy Member | Deputy Member | 2024 | — | — |
JO Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
PT Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
LR Deputy Member | Deputy Member | 2022 | — | — |
KE Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
KJ Deputy Member | Deputy Member | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Orkla Wound Care Ab | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORGESPLASTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christina Tellefsen | Deputy Member | 0 companies |
| Louise Agnes Marie Wassberg | Deputy Member | 0 companies |
| Jan Ola Carlstein | Chief Executive Officer | 0 companies |
| Per Turnes | Chief Executive Officer | 0 companies |
| Leif Rune Grinde | Deputy Member | 0 companies |
| Knut Eckhoff | Chief Executive Officer | 0 companies |
| Karen Jebsen Lundal | Deputy Member | 0 companies |
| Christian Rykke | Chairman | 0 companies |
| Erik Smith-Hansen | Board of Directors | 0 companies |
| Marit Agner Matheson | Board of Directors | 0 companies |
| Rune Stensland | Board of Directors | 0 companies |
| Otto Tobiassen | Board of Directors | 0 companies |
| Maria Kristina Lundman Hedberg | Chairman | 0 companies |
| Eva Madeleine Samuelson | Board of Directors | 0 companies |
| Gunilla Christina Elisabet Hägglund | Board of Directors | 0 companies |
| Are Nakkim | Board of Directors | 0 companies |